Can Anyone Get Ozempic? What You Need to Know About Eligibility and Use

Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide was originally developed to treat type 2 diabetes, and its ability to lower blood sugar and reduce appetite has made it relevant for millions of Americans. However, not everyone needs or qualifies for this medication, and eligibility depends on specific medical factors, health history, and treatment goals. Understanding who can safely use semaglutide helps patients and providers make informed decisions about personalized weight management.

Medical Conditions That Support Semaglutide Eligibility

Semaglutide is approved by the FDA for adults with type 2 diabetes or a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with weight-related health conditions. Common qualifying conditions include hypertension, high cholesterol, prediabetes, and sleep apnea. Patients with a personal or family history of cardiovascular disease may also benefit from semaglutide's metabolic effects. Your medical provider evaluates these factors during an initial consultation to determine if the medication aligns with your health profile.

Beyond FDA-approved indications, some patients qualify based on metabolic risk factors identified through blood work and lifestyle assessment. Elevated fasting glucose, insulin resistance, and fatty liver disease can signal a need for GLP-1 therapy even at lower BMI thresholds. PlexusDx providers consider the full clinical picture, not just a single number, to determine whether semaglutide is appropriate for your specific situation.

Age, Pregnancy, and Contraindications to Semaglutide

Semaglutide is approved for adults 18 years and older; safety in pediatric populations outside of type 2 diabetes remains limited. Pregnant women and those planning pregnancy should not use semaglutide, as animal studies have raised concerns about fetal development. Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2) cannot safely receive semaglutide due to theoretical thyroid risk. A comprehensive health history review with your PlexusDx provider identifies these contraindications before treatment begins.

Certain medications, including other GLP-1 agonists or SGLT2 inhibitors, may interact with semaglutide or make combination therapy unnecessary. Patients with severe kidney disease or recent pancreatitis require careful evaluation. PlexusDx requires a detailed medication and surgical history to rule out absolute contraindications and optimize your treatment plan safely.

How PlexusDx Determines Your Semaglutide Eligibility

PlexusDx uses a multi-step eligibility process that begins with a detailed questionnaire covering your weight history, metabolic markers, medications, and family health background. A licensed provider reviews your information and may request recent lab work such as fasting glucose, lipid panel, or thyroid function tests to confirm suitability. This personalized approach ensures you receive semaglutide only if it matches your specific health needs and goals. The entire process is streamlined to get you answers quickly without unnecessary delays.

Once approved, PlexusDx delivers compounded semaglutide injections from licensed 503A compounding pharmacies directly to your door, starting at $149 per month with no membership fees or insurance required. Your dose may need to go up as your body adjusts, but your price won't. HSA and FSA accounts are accepted, making treatment accessible across diverse financial situations. PlexusDx also offers the optional Precision Peptide Genetic Test ($99 add-on after your first month) to identify genetic insights into your peptide response and optimize long-term outcomes.

Exclusion Factors and When Semaglutide Is Not Appropriate

Certain medical histories automatically exclude patients from semaglutide use. These include active or recent thyroid cancer, severe diabetic retinopathy, acute gallbladder or pancreas disease, or uncontrolled severe hypoglycemia in type 2 diabetes patients. Patients with a BMI under 25 without metabolic disease typically do not meet eligibility criteria. Previous allergic reactions to semaglutide or any component of the injection formulation also contraindicate use. PlexusDx providers are trained to identify these exclusions early and discuss alternative approaches if semaglutide is not suitable.

Lifestyle factors matter too. Patients unwilling to commit to dietary changes, regular physical activity, or ongoing medical monitoring may not achieve optimal results with semaglutide alone. The medication is most effective as part of a comprehensive weight management strategy, not as a standalone solution. If semaglutide is inappropriate for your situation, PlexusDx providers can discuss other compounded GLP-1 options, oral formulations, or microdose protocols that may better fit your clinical profile.

Access and Affordability: Removing Barriers to Eligibility

Insurance denial or lack of coverage has historically prevented eligible patients from accessing semaglutide. PlexusDx bypasses this barrier by offering compounded semaglutide injections nationwide without requiring insurance, starting at $149 per month across all 50 states. This transparent, flat-rate pricing model removes the guesswork and cost surprises that often discourage eligible patients from seeking treatment. You can start therapy immediately after provider approval, without waiting for insurance authorizations.

PlexusDx accepts HSA and FSA funds, further reducing out-of-pocket expenses for many patients. For those exploring whether semaglutide is right for them, the low entry cost makes it feasible to begin therapy and assess your individual response. If you later opt for the Precision Peptide Genetic Test ($99), PlexusDx can refine your treatment protocol based on your genetic predispositions to GLP-1 effectiveness, helping justify the investment in personalized care.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I need to have type 2 diabetes to qualify for semaglutide through PlexusDx?

No. While semaglutide is FDA-approved for diabetes, PlexusDx also evaluates patients for weight management and metabolic health regardless of diabetes status. A BMI of 30 or higher, or 27 with weight-related conditions like hypertension or sleep apnea, can qualify you. Your PlexusDx provider reviews your complete health profile to determine eligibility.

What blood work do I need before starting semaglutide?

PlexusDx typically requests fasting glucose, lipid panel, kidney function, and thyroid markers to confirm semaglutide safety and establish a baseline for monitoring. If you have recent labs from your primary care doctor, PlexusDx can often use those. Some patients may need additional testing if they have specific health concerns or medication interactions to evaluate.

Can I get semaglutide if I have no insurance?

Yes, absolutely. PlexusDx serves all 50 states without requiring insurance, offering compounded semaglutide injections starting at $149/month with no membership fees. HSA and FSA accounts are also accepted, giving you flexible payment options regardless of insurance status.

What side effects might disqualify me from semaglutide, or should I avoid it?

A history of pancreatitis, severe kidney disease, or personal/family history of medullary thyroid cancer are serious concerns. Common side effects include nausea, vomiting, and constipation, which are usually manageable but sometimes require dose adjustment. PlexusDx providers monitor your tolerance and adjust your protocol if side effects become problematic.

How does the Precision Peptide Genetic Test help determine if semaglutide is right for me?

PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) examines genetic variants in GLP1R, GIPR, FTO, and MC4R pathways to predict your individual response to GLP-1 therapy. This genetic insight helps optimize your dose and protocol, ensuring semaglutide delivers maximum benefit based on your biology, not a one-size-fits-all approach.

Related Reading

• Genetic Testing 101 What You Need To Know Before Getting Tested
• What Genetic Factors Determine How Much Sleep You Need Each Night
• Lifemd Ozempic
• Eden Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.